It’s been a good week if you enjoy a little GMO schadenfreude. The FDA has reportedly bowed to public pressure to extend the comment period on its approval of genetically engineered salmon, and Illinois, Maryland, and Iowa are the latest states to buck GMOs by introducing labeling bills into state legislature.
Even the Supreme Court has an opportunity to take Monsanto down a peg. On Feb. 19, the court will hear arguments in a patent infringement case between an Indiana farmer and Monsanto (I covered it in detail here). If Monsanto prevails, it’ll move a few more paces towards agricultural monopoly; if it loses, the company will take a couple steps back. It’s encouraging that the Supreme Court chose to hear the case over the solicitor general’s urging to dismiss it, but Monsanto could have an inside man: As in other Monsanto-related cases, former Monsanto-lawyer-turned-Supreme-Court-Justice Clarence Thomas has no plans to recuse himself.